Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
ohm20's Profile
Displaying 1501-1550 of 6028 result(s).
CYDY CytoDyn Inc
06/10/2022 9:01:34 AM
I was suggesting the density of the (4)
CYDY CytoDyn Inc
06/10/2022 8:56:32 AM
however we do not know exactly how (10)
CYDY CytoDyn Inc
06/10/2022 8:52:16 AM
Could it be the age of the scar tis (5)
CYDY CytoDyn Inc
06/10/2022 12:41:03 AM
Remember about a year ago, when I w (8)
CYDY CytoDyn Inc
06/09/2022 7:36:42 PM
We definitely need more information (7)
CYDY CytoDyn Inc
06/09/2022 1:06:37 PM
After 2 1/2 years they're finally c (8)
CYDY CytoDyn Inc
06/09/2022 12:55:37 PM
Being a PD-1 inhibitor dostarlimab (6)
CYDY CytoDyn Inc
06/08/2022 10:55:51 AM
trastu-leron...nice ring to it. Ler (6)
CYDY CytoDyn Inc
06/08/2022 12:17:42 AM
I took a look at the the deruxtecan (17)
CYDY CytoDyn Inc
06/06/2022 11:57:34 PM
and given the work being done at MD (8)
CYDY CytoDyn Inc
06/06/2022 12:47:57 PM
I wouldn't expect just a PD-1 inhib (1)
CYDY CytoDyn Inc
06/06/2022 12:42:51 PM
"The medians fail us to some degree (3)
CYDY CytoDyn Inc
06/06/2022 1:31:40 AM
Just bear in mind, Enhertu is not u (4)
CYDY CytoDyn Inc
06/06/2022 1:13:51 AM
How many were alive in November? Mo (4)
CYDY CytoDyn Inc
06/06/2022 1:02:27 AM
As I've said before that 27% improv (8)
CYDY CytoDyn Inc
06/06/2022 12:50:18 AM
It's listed right in that abstract. (3)
CYDY CytoDyn Inc
06/06/2022 12:39:14 AM
The deruxtecan portion of that drug (7)
CYDY CytoDyn Inc
06/04/2022 6:34:52 PM
Hopefully they are using a PD-1 inh (7)
CYDY CytoDyn Inc
06/02/2022 8:18:43 PM
Another refuse-to-file for a small (9)
CYDY CytoDyn Inc
06/02/2022 6:23:05 PM
Cencriviroc, maraviroc and those th (2)
CYDY CytoDyn Inc
06/02/2022 1:51:46 PM
Where did the CCR5 come from? From (2)
CYDY CytoDyn Inc
06/02/2022 1:48:55 PM
As far as legal issues, by the acti
CYDY CytoDyn Inc
06/02/2022 10:28:22 AM
With Urbach's aversion to legal iss
CYDY CytoDyn Inc
06/02/2022 10:26:16 AM
When CCR5 is internalized, it is no (3)
CYDY CytoDyn Inc
06/02/2022 8:07:28 AM
I was wrong. Looking at Dr. Sacha's (9)
CYDY CytoDyn Inc
06/01/2022 6:21:55 PM
Interferon Gamma, Alpha would get e (8)
CYDY CytoDyn Inc
06/01/2022 2:24:31 PM
You're probably saying that if Lero (6)
CYDY CytoDyn Inc
06/01/2022 10:14:12 AM
i don't follow this side of things (7)
CYDY CytoDyn Inc
05/31/2022 10:45:06 PM
The question that requires asking & (2)
CYDY CytoDyn Inc
05/31/2022 10:34:19 PM
Urbach doesn't seem to realize that (9)
CYDY CytoDyn Inc
05/31/2022 10:31:46 PM
The upregulation in CCR5 expression (1)
CYDY CytoDyn Inc
05/31/2022 10:17:18 PM
Bruce's test kits were for checking (10)
CYDY CytoDyn Inc
05/31/2022 10:15:11 PM
Unfortunately we haven't been able
CYDY CytoDyn Inc
05/31/2022 10:12:12 PM
I was quite surprised that he sold. (1)
CYDY CytoDyn Inc
05/31/2022 10:09:57 PM
When I framed who would be best as (7)
CYDY CytoDyn Inc
05/31/2022 10:07:41 PM
I think Dr. Lalezari is with Cytody (14)
CYDY CytoDyn Inc
05/31/2022 4:14:22 PM
I do not know Pestells cost basis o (1)
CYDY CytoDyn Inc
05/31/2022 4:11:32 PM
I believe Pestell sold a bunch eith
CYDY CytoDyn Inc
05/31/2022 4:08:31 PM
Regarding your question about Peste (3)
CYDY CytoDyn Inc
05/31/2022 8:53:10 AM
Pestell wouldn't agree to be termin (1)
CYDY CytoDyn Inc
05/30/2022 12:46:38 AM
The FDA has accepted mixed data bef (5)
CYDY CytoDyn Inc
05/29/2022 4:55:02 AM
The results prove it out. Whether w (12)
CYDY CytoDyn Inc
05/28/2022 10:33:03 PM
Pts received 1-33 doses Which tells (10)
CYDY CytoDyn Inc
05/28/2022 10:14:02 PM
Leronlimab would reduce glutamine m (5)
CYDY CytoDyn Inc
05/28/2022 9:56:13 PM
That they wiped out so much on the (14)
CYDY CytoDyn Inc
05/28/2022 9:39:54 PM
For dosing we really don't know exa (6)
CYDY CytoDyn Inc
05/27/2022 11:47:19 PM
Kelly basically said BTD is out of (3)
CYDY CytoDyn Inc
05/27/2022 11:30:49 PM
Serum concentration of leronlimab v (6)
CYDY CytoDyn Inc
05/27/2022 9:08:38 AM
LL dislodges CCL5 from these CCR5 r (16)
CYDY CytoDyn Inc
05/26/2022 9:51:34 PM
Study completion date 2024 That's t (3)
Go to page:
  • << First
  • < Previous
  • 30
  • 31
  • Next >

Recent Articles

  • EnGenius Unveils Transformative Wi-Fi 7 Access Point for SMBs
  • Innovative VoIP Acquisition Shakes Up Tech Industry Dynamics
  • ModelCat: Transforming the AI Landscape with a New Identity
  • Identity Dental Marketing Tops Rankings for Dentist SEO Strategies
  • FDCTech's Alchemy Markets Unveils Innovative Copy Trading App
  • Moleculin Raises $6 Million Through Accelerated Warrant Exercise
  • Waste Recycling Services Market Trends Projecting Future Growth
  • SOLOWIN's Chainlink Integration Elevates Tokenized Finance Standards
  • Unlocking Value: ESGold Corp's Eco-Friendly Mining Revolution
  • GlobalFoundries Unveils Powerful 130CBIC SiGe Platform
  • Alarum Technologies Reports Impressive Q2 2025 Financial Results
  • Surge in Silver Prices Sparks Interest in Sprott ETFs
  • Jim Cramer Highlights Rigetti's Speculative Growth Potential
  • Cooper Companies Faces Setback in Pre-Market Trading Today
  • Perimeter Medical Welcomes Dr. Ted James as New CMO
  • NurExone Biologic Inc. Reports Financial Progress and Updates
  • Alarum Technologies Reports Positive Q2 2025 Financial Results
  • Analysts Update Expectations for Marvell Technology Earnings
  • StartekĀ® Achieves Prestigious Women Empowerment Certification
  • 2025 Automotive Brand Loyalty Trends Highlight Changes Ahead
  • CGI Enhances Its Digital Services with Apside Acquisition
  • Dominari Holdings Unveils Strategic $2 Billion Fund for Growth
  • CTO Realty Growth, Inc. Faces Class Action Lawsuit Concerns
  • The St. James Reinvents Lacrosse with Spencer Ford at the Helm
  • GraniteShares Unveils Weekly Distribution for YieldBOOST ETFs
  • SOLOWIN Innovates Tokenized Asset Transparency with Chainlink
  • ARS Pharmaceuticals Schedules Key Presentations for Investors
  • Kyverna Therapeutics Advances Innovative CAR T Therapy for MG
  • Seluna Advances Pediatric Sleep Diagnostics with New Study
  • CytomX Therapeutics Engages Investors at Key Conferences
  • Exploring the Growth of Parkinson's Disease Therapies to 2034
  • Psyence BioMed, a Leader in Psychedelic Medicine, Pursues Growth
  • Kot Auto Group Partners with AutoTrader.ca to Boost Sales
  • CryptoVirally Enhances Web3 Marketing Services for Growth
  • Marker Therapeutics' Strategic Participation in Key Conference
  • NurExone Biologic Inc. Reports Strong Q2 Financial Outcomes
  • ExlService Holdings Plans to Engage at Citi TMT Conference
  • Catalyst Pharmaceuticals Gears Up for Key Investor Engagements
  • CF Energy Reports Comprehensive Financial Performance Analysis
  • Celebrate Racing Excellence at Kentucky Downs' Rich Events
  • Marker Therapeutics CEO to Speak at Key Investment Conference
  • Candel Therapeutics Announces Participation in Key Investor Events
  • EXL's Key Presentation at the Citi Global TMT Conference
  • Join VEON and Kyivstar for Key Insights into Future Growth
  • Catalyst Pharmaceuticals Engages Investors at Key Conferences
  • Czech Army Strengthens Defense with BAE Systems' New Vehicle
  • Ribbon Communications Enhances Defense Solutions for Secure Networks
  • Understanding XRP's Market Dynamics and Ongoing Criticism
  • Candel Therapeutics to Engage Investors at Major Conferences
  • LakeShore Biopharma Engages in Acquisition Talks Amid Growth
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site